Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Post by somweyungguyon Oct 05, 2016 3:07pm

72 Views

Post# 25313259

Write our BoD member too.. Mr.Takeshita of Toray

Honourable enough not accept 1 option

Ask him to inquire with Toray as to how they feel about the FDA set trial set up

There ya Josher a little job to take your mind off being the assigned gatekeeper.

Warm regards,
OsakaAvalanche

PS - send it STRAIGHT to Japan...mail might get lost @ 135

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property